Sanjay Mistry
VP Venture Investments at Johnson & Johnson
San Diego, California
Overview
Work Experience
Director Board of Directors
2024 - Current
Board Observer
2021
Vice President Venture Investments New Company Creation - Johnson & Johnson Innovation – JJDC Inc.
2021
Senior investment professional leading new company creation for Johnson & Johnson Innovation – JJDC, Inc., the strategic venture capital arm of the Johnson & Johnson Family of Companies. Primary responsibility is to fund compelling innovation where we see an opportunity to transform and enhance patient outcomes through the creation of innovative healthcare start-up companies.
Head JLABS @ San Diego, Johnson & Johnson Innovation
2019 - 2021
Nurtured the growth of San Diego’s entrepreneurial start-ups focusing on accelerating the pace of innovation that is critical for translating discoveries into products for patients
Senior Finance Director Business Operations for Janssen Pharmaceuticals R&D
2018 - 2019
Reported to Janssen Pharmaceuticals R&D CFO
Head of External Value Creation & Business Operations/Venture Leader
2013 - 2018
Led Janssen R&D efforts on launching NewCo’s via the out-licensing of R&D pre-clinical/clinical portfolio assets to biotech’s, pharma’s or into venture backed entities Led Janssen R&D Internal Venture Incubator operations focused on disruptive drug discovery assets/platforms that could generate new business models/innovation within or external to Janssen beyond core strategic focus areas EIR for 2 internal ventures
Johnson & Johnson is a healthcare provider, expertise in innovative medicine and MedTech for every patient & for everyone.
Director Board of Directors
2022 - 2024
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Raised $250,000,000.00 from Sofinnova Investments, T. Rowe Price, Johnson & Johnson Innovation – JJDC, Surveyor Capital, Goldman Sachs Asset Management, Perceptive Advisors, Third Rock Ventures, Logos Capital, Fidelity and ARCH Venture Partners.
Vice President
2008 - 2013
Board Observer Roles: Raindance Technologies, Tarsa Therapeutics, Corridor Pharmaceuticals, Rapid Micro Biosystems, Durata Therapeutics (PIPE)
Quaker Partners is a healthcare investment firm focused on companies based on the U.S. East Coast.
Assistant Director
2003 - 2008
Inventor of cell therapy for the treatment of age-related macular degeneration (Phase iIIb)
Johnson & Johnson is a healthcare provider, expertise in innovative medicine and MedTech for every patient & for everyone.
Development Scientist
2002 - 2003
Established stem cell molecular biology group and discovered and developed muscle derived stem cell platform
Postdoctoral Fellow
2000 - 2001
Investigated the role of neural cell adhesion molecules in the initiation of stem cell differentiation and integration in targeted organogenesis (Laboratory of Dr. G. Edelman, Nobel laureate)
Postdoctoral Fellow
1998 - 2000
Department of Biochemistry: Investigated the role of arginase in arginine metabolism in wound healing and trauma (Laboratory of Dr. S. Morris)